Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Insulin-Dependent”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00039026
What this trial is testing

Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With a Sulfonylurea

Who this might be right for
Diabetes Mellitus, Non-Insulin-Dependent
AstraZeneca 377
Not applicableStudy completedNCT00519935
What this trial is testing

Testing MST to Improve Adherence Among Youth With Chronic Poor Metabolic Control

Who this might be right for
Type 1 Diabetes
Wayne State University 127
Not applicableStudy completedNCT01694758
What this trial is testing

OPtimal Type 2 dIabetes Management Including Benchmarking and Standard Treatment in CEEMEA

Who this might be right for
Diabetes Mellitus, Non-Insulin-Dependent
AstraZeneca 733
Testing effectiveness (Phase 2)UnknownNCT05659368
What this trial is testing

Tirzepatide Monotherapy in Patients With Wolfram Syndrome Type 1

Who this might be right for
Wolfram Syndrome
Ospedale San Raffaele 10
Testing effectiveness (Phase 2)Study completedNCT04074317
What this trial is testing

Phase 2, Randomized, Open-Label, Crossover, PD/PK Study of a Novel Pram-Insulin Co-Formulation in Adults With T1D

Who this might be right for
Diabetes Mellitus, Type 1Insulin-dependent Diabetes Mellitus
Xeris Pharmaceuticals 18
Testing effectiveness (Phase 2)Looking for participantsNCT05824975
What this trial is testing

Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorSoft Tissue Sarcoma (STS)+6 more
GI Innovation, Inc. 358
Large-scale testing (Phase 3)Study completedNCT00166673
What this trial is testing

Pilot Study of the Navigator Continuous Glucose Monitor

Who this might be right for
Diabetes Mellitus, Insulin-Dependent
Jaeb Center for Health Research 60
Not applicableStudy completedNCT00005462
What this trial is testing

Genetics of Atherosclerosis in Mexican Americans

Who this might be right for
Cardiovascular DiseasesCoronary DiseaseObesity+3 more
National Heart, Lung, and Blood Institute (NHLBI)
Post-approval studies (Phase 4)Study completedNCT00318656
What this trial is testing

24-Hour Glycemia: Rosiglitazone Versus Glimepiride In Type 2 Diabetes

Who this might be right for
Non-Insulin-Dependent Diabetes Mellitus
GlaxoSmithKline 23
Testing effectiveness (Phase 2)Study completedNCT01548729
What this trial is testing

Metabolic Efficiency of Combined Pancreatic Islet and Lung Transplant for the Treatment of End-Stage Cystic Fibrosis

Who this might be right for
Cystic FibrosisDiabetes Related Cystic FibrosisInsulin-dependent Diabetes
University Hospital, Strasbourg, France 14
Not applicableStudy completedNCT00005539
What this trial is testing

Wisconsin Epidemiological Study of Cardiovascular Disease in Type 1 Diabetes

Who this might be right for
Cardiovascular DiseasesDiabetes MellitusHeart Diseases+1 more
University of Wisconsin, Madison
Testing effectiveness (Phase 2)Study completedNCT02970981
What this trial is testing

Study of Combination of Ipilimumab and Nivolumab in Patients With Melanoma

Who this might be right for
Melanoma
NYU Langone Health 18
Testing effectiveness (Phase 2)Study completedNCT00065312
What this trial is testing

An Evaluation of an Oral Antidiabetic Agent for the Treatment of Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Non-Insulin-Dependent
Eli Lilly and Company
Post-approval studies (Phase 4)Study completedNCT02481479
What this trial is testing

Saxagliptin and Cardiac Structure and Function

Who this might be right for
Diabetes Mellitus, Non-Insulin-DependentHeart Failure
Unity Health Toronto 18
Testing effectiveness (Phase 2)UnknownNCT01322789
What this trial is testing

Safety and Efficacy of Mesenchymal Stem Cells in Newly-diagnosed Type 1 Diabetic Patients

Who this might be right for
Diabetes Mellitus, Insulin-Dependent
University of Sao Paulo 10
Not applicableStudy completedNCT02939768
What this trial is testing

Impact of Different Types of Exercise Training on Biochemical Markers of Insulin-dependent Patients

Who this might be right for
Diabetes Mellitus, Type 1
Federal University of Rio Grande do Sul 28
Not applicableStudy completedNCT00713440
What this trial is testing

Incretin Physiology Associated With Steroid Hormone Treatment

Who this might be right for
Type 2 Diabetes MellitusSteroids
Glostrup University Hospital, Copenhagen 10
Large-scale testing (Phase 3)UnknownNCT01559025
What this trial is testing

Evaluation of Vildagliptin (Galvus®) as add-on to Insulin in New-onset Type 1 Diabetes Mellitus

Who this might be right for
Type 1 DiabetesInsulin Dependent DiabetesJuvenile Onset Diabetes Mellitus+1 more
Federal University of São Paulo 44
Post-approval studies (Phase 4)Not Yet RecruitingNCT07004335
What this trial is testing

Efficacy and Safety of Iparomlimab and Tuvonralimab Injection in Combination With Bevacizumab After Progression on Anti-PD-(L)1 Therapy in Advanced Melanoma: A Prospective, Single-Arm, Exploratory Clinical Study

Who this might be right for
PD-(L)1CTLA-4Advanced Melanoma+3 more
Hebei Medical University Fourth Hospital 40
Testing effectiveness (Phase 2)Study completedNCT02801448
What this trial is testing

Clinical Trial With Broccoli Sprout Extract to Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Non-Insulin-Dependent
Anders Rosengren, MD PhD 103
Next Page